Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Capital Leases: 2016-2018

Historic Capital Leases for Editas Medicine (EDIT) over the last 3 years, with Dec 2018 value amounting to $32.4 million.

  • Editas Medicine's Capital Leases fell 3.03% to $32.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $32.4 million, marking a year-over-year decrease of 3.03%. This contributed to the annual value of $32.4 million for FY2018, which is 3.03% down from last year.
  • Latest data reveals that Editas Medicine reported Capital Leases of $32.4 million as of Q4 2018, which was down 0.85% from $32.7 million recorded in Q3 2018.
  • Over the past 5 years, Editas Medicine's Capital Leases peaked at $35.1 million during Q4 2016, and registered a low of $11.6 million during Q1 2016.
  • Its 3-year average for Capital Leases is $30.6 million, with a median of $33.1 million in 2018.
  • Over the last 5 years, Editas Medicine's Capital Leases had its largest YoY gain of 191.26% in 2017, and its largest YoY loss of 4.74% in 2017.
  • Editas Medicine's Capital Leases (Quarterly) stood at $35.1 million in 2016, then dropped by 4.74% to $33.4 million in 2017, then dropped by 3.03% to $32.4 million in 2018.
  • Its Capital Leases was $32.4 million in Q4 2018, compared to $32.7 million in Q3 2018 and $32.9 million in Q2 2018.